The Medicines Co. price target raised to $38 from $30 at WallachBeth WallachBeth raised its price target for The Medicines Co. shares following the company's Q4 results and reiterates a Buy rating on the stock.
News For MDCO From The Last 14 Days
Check below for free stories on MDCO the last two weeks.